Reconsidering the Interpretation of “Recurrence-Free Survival” After Mastectomy for DCIS. Comment on Sae-sim et al. Tamoxifen Reduces Breast Cancer Recurrence in Women with DCIS Who Underwent Mastectomy. Curr. Oncol. 2026, 33, 89

Authors

Institutions

Publication Details

Journal
Current Oncology
Published
2026-04-17
DOI
https://doi.org/10.3390/curroncol33040223
Citations
1
Primary Topic
Breast Cancer Treatment Studies
Type
article
Field-Weighted Citation Impact
14.55
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Reconsidering the Interpretation of “Recurrence-Free Survival” After Mastectomy for DCIS. Comment on Sae-sim et al. Tamoxifen Reduces Breast Cancer Recurrence in Women with DCIS Who Underwent Mastectomy. Curr. Oncol. 2026, 33, 89

Janhavi Venkataraman, Kefah Mokbel
1 citations
Current Oncology
Breast Cancer Treatment Studies
14.55
article

Reconsidering the Interpretation of “Recurrence-Free Survival” After Mastectomy for DCIS. Comment on Sae-sim et al. Tamoxifen Reduces Breast Cancer Recurrence in Women with DCIS Who Underwent Mastectomy. Curr. Oncol. 2026, 33, 89

Janhavi Venkataraman, Kefah Mokbel
article en
1 citations

Abstract

No abstract available for this paper.
Current OncologyVol. 33(4)
The Princess Grace Hospital (GB)
Good health and well-being
Openalex Percentile: Top 1%
Breast Cancer Treatment Studies
14.55
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.